PTC THERAPEUTICS, INC. — Director's Dealing 2021

Apr 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-04-13

Reporting Person: Peltz Stuart Walter (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-13	Common Stock	A	1400	—	Acquired	16481	Indirect

Footnotes

F1: Restricted stock units granted on April 13, 2021 that vest in four equal installments over four years, commencing on April 13, 2022.